ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681634 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681634; 2) Community: the network communities that were significantly associated with the response to NSC 681634; 3) Molecule: the relationships between components within communities and NSC 681634; 4) MDR: the compounds that were significantly associated with the NSC 681634.

NSC Compound Enrichment Correlation
NSC 761826 (Z)-3-((1-(4-fluoro-3-methoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.04831289866584 0.0168352
NSC 105014 Cladribine 0.0490935610249067 0.54995007
NSC 132313 Dianhydrogalactitol 0.0490935610249067 0.71670765
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0490935610249067 0.353544
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0490935610249067 0.18684816
NSC 166382 Null 0.0490935610249067 -0.043857983
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0490935610249067 0.41258798
NSC 328410 Camptothecin Derivative 0.0490935610249067 0.58167155
NSC 615534 Null 0.0490935610249067 0.18765777
NSC 619030 Analog of CC-1065 0.0490935610249067 0.68009405
Total:49  Current:46    [First] [Prev] [Next] [Last]